Immunovant [IMVT] vs S&P 500 [^GSPC] Detailed Stock Comparison
Immunovant
NASDAQ
Loading...
S&P 500
index
Loading...
Index Comparison
You are comparing market indices. Financial metrics such as P/E ratios, dividend yields, and financial statements are not available for indices as they represent market benchmarks rather than individual companies.
Available data includes: price performance, historical charts, and basic market statistics.
Performance
Key Stats
Immunovant vs S&P 500 Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Immunovant | 0.13% | -2.37% | -16.16% | 2.98% | -30.23% | -41.09% |
| S&P 500 | -0.40% | -1.52% | 1.02% | 8.99% | 5.94% | 8.55% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Immunovant | -54.23% | 150.25% | -57.60% | 49.15% | 49.15% | 49.15% |
| S&P 500 | 13.05% | 56.99% | 81.59% | 220.29% | 498.37% | 428.60% |